Corcept Therapeutics Zoomed Nearly: What Fueled the Week
This week brought a notable rise for Corcept Therapeutics as investors reacted to a major catalyst. Learn what drove ...
Compare safety profiles of SP500 and Total Market funds for retirement, focusing on diversification, drawdown risk, and historical resilience.
28,493 articlesThis week brought a notable rise for Corcept Therapeutics as investors reacted to a major catalyst. Learn what drove ...
A bold claim from a top energy chief has investors reassessing risk. This guide breaks down what a tight oil market c...
The Caesars deal upends the regional gaming scene and shifts attention to which casino stocks could be the next buyou...
Stocks wobbled as a memory-chip selloff led by South Korea dragged down Micron and peers. This article breaks down wh...
A major cold storage leader caught the eye of a notable investor, who disclosed a fresh stake worth $19 million. This...
A new permanent-capital firm aims to acquire cash-flowing U.S. businesses from aging founders, paying part in stock a...
A veteran diplomat weighs the odds of regime change in Iran as U.S.-led strikes escalate, warning that history in the...
Oil prices jumped as traders priced a roughly four-week disruption to supply. Goldman Sachs analysts say the move ref...
Microsoft kicks off 2026 with a rough start as earnings beat clashes with a surge in capital expenditures. Traders de...
Young men are flocking to prediction markets for quick payouts and heightened excitement, but analysts warn the bets ...
Berkshire Hathaway stands out as a core, set-it-and-forget-it holding as markets wobble in 2026. Its fortress balance...
The annual Sun Valley meeting is pivoting from legacy media power to AI and software influence, signaling a new era f...